
样式: 排序: IF: - GO 导出 标记为已读
-
The Dynamics of Deceased Donor Kidney Transplant Decision-Making: Insights from Studying Individual Clinicians' Offer Decisions. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-31 Ellen Green,E Glenn Dutcher,Jesse D Schold,Darren Stewart
Despite the high demand, over 7,500 recovered kidneys annually go unused, with transplant centers showing significant variation in their offer acceptance practices. However, it remains unclear how much of this variation occurs between individual clinicians within the same center and its impact on allocation efficiency and equity. This study quantified the variability in kidney offer acceptance decisions
-
Response to "The under-reporting of liver machine perfusion in US national data". Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-31 Stalin Canizares,David D Lee
-
Fewer medullary pyramids in the living kidney donor associate with graft failure in the recipient. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-30 Samy M Riad,Naim Issa,Aleksandar Denic,Timothy L Kline,Adriana V Gregory,Joshua Augustine,Fawaz Al Ammary,Tony C Luehrs,Aidan F Mullan,Andrew D Rule
This study aimed to identify the parenchymal structural features by both CT and histology that associate with death-censored graft failure in recipients of living donor kidneys. We analyzed kidney recipients of ABO-compatible living donor kidneys from 2000-2020 with follow-up through 2023. Cortical volume and thickness, individual medullary pyramid volume and count, glomerular volume, nephrosclerosis
-
Clinical predictors for restrictive allograft syndrome: a nested case-control study. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-30 Hanne Beeckmans,Pieterjan Kerckhof,Acet Öztürk Nilufer,Andrea Zajacova,Jan Van Slambrouck,Saskia Bos,Marie Vermant,Lyne O Van Dieren,Tessa Goeminne,Christelle Vandevelde,Josephine Bardyn,Elisabeth Willems,Sam Lauriers,Marius Brusselmans,Leen Van Langenhoven,Marie Paule Emonds,Steffi De Pelsmaeker,Johan Kerkhofs,Laurens De Sadeleer,Laurent Godinas,Lieven J Dupont,Dirk E Van Raemdonck,Laurens J Ceulemans
Risk factors for restrictive allograft syndrome (RAS), a severe phenotype of chronic lung allograft dysfunction after lung transplantation, are currently not well known. In this retrospective nested case-control-study, we analyzed 69 RAS patients and 69 matched non-CLAD controls to identify clinical risk factors for RAS. RAS patients demonstrated overall higher blood eosinophils (p=0.02), increased
-
Risk and prognosis of post-transplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - An observational cohort study from Norway and western Denmark. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-28 Lene Ugilt Pagter Ludvigsen,Anders Åsberg,Signe Spetalen,Mia Dahl Sørensen,Stephen Hamilton-Dutoit,Ann-Maria Gramkow,Christian Fynbo Christiansen,Grete Birkeland Kro,Marianne Kragh Thomsen,Sinna Pilgaard Ulrichsen,Rune Micha Pedersen,Harald Holte,Helle Charlotte Thiesson,Anna Bjerre,Francesco D'Amore,Dag Olav Dahle,Bente Jespersen,Søren Jensen-Fangel,Anna Varberg Reisæter
Post-transplant lymphoproliferative disorder (PTLD) poses a serious challenge in kidney transplant recipients. Epstein-Barr virus (EBV)-seronegative recipients have a significantly increased risk of PTLD, but few studies have investigated risk factors for PTLD in EBV-seronegative recipients in the current era of immunosuppression. This cohort study from Norway and western Denmark included first-time
-
HMGB1-mediated CIITA super-enhancers are critical for DC trained immunity in acute-to-chronic progression of allograft rejection. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-28 Lingjuan Sun,Xiangli Zhao,Xiaosheng Tan,Liu Song,Zhibo Ma,Jingzeng Wang,Peixiang Lan,Song Chen,Gang Chen
Chronic allograft rejection is mainly mediated by indirect recognition. Dendritic cells (DCs), as the major antigen-presenting cells in indirect recognition, exhibit an enhanced antigen-presenting ability in chronic rejection, but the specific mechanism is still unclear. Here, we found that pretreatment with high mobility group box-1 protein (HMGB1) in vivo can induce trained immunity in DCs. These
-
Letermovir should be first-line cytomegalovirus prophylaxis in lung transplant recipients. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-28 A K Mezochow,E Clausen,K Whitaker,T Claridge,E Blumberg,A M Courtwright
Universal cytomegalovirus (CMV) prophylaxis is recommended for at-risk lung transplant recipients. Valganciclovir is currently the preferred first-line agent. Valganciclovir-related myelosuppression, however, can lead to drug discontinuation or reduction in anti-metabolite immunosuppression. Variable valganciclovir pharmacokinetics in the setting of renal injury are also associated with development
-
Impact of the lung allocation system score modification by blood type on US lung transplant candidates. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-28 Grace R Lyden,Maryam Valapour,Nicholas L Wood,Sommer E Gentry,Ajay K Israni,Ryutaro Hirose,Jon J Snyder
The lung continuous distribution system was modified on September 27, 2023, with the goal of increasing transplant access for blood-type-O candidates after an error was discovered in the simulation used to support the development of the initial allocation policy. This retrospective observational study compares national waitlist outcomes (transplant rate, waitlist mortality) under continuous distribution
-
Development and validation of the Neuro-Score: a specific scale to detect and monitor cognitive impairment in kidney or liver transplant recipients. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-28 Francesc Moreso,José Antonio Pons Miñano,Ana Sánchez Fructuoso,Carlos Jacas,Montserrat Alegret,Montserrat Ferrer,Jordi Colmenero Arroyo,Amado Andrés Belmonte,Verónica López Jiménez,Sonia Pascual,Auxiliadora Mazuecos Blanca,Ana Paz Ventura Galiano,Alba Cachero,Antonio Rivero,Marta Crespo,Antonio Cuadrado,Arantxa Caballero Marcos,Maria Luisa Gonzalez Diéguez,Carolina Almohalla Alvarez,Naroa Maruri Kareaga
We created and validated the Neuro-Score, a specific scale to detect and monitor cognitive impairment, including mild stages, in kidney or liver transplant recipients. A qualitative study was conducted to define a preliminary set of 62 items. Item reduction was performed using exploratory factor analysis. Confirmatory factor analysis assessed the adequacy of the factorial solution. The total scores
-
Transforming Transplantation Access: A Federal Directive for Comprehensive Pre-Waitlisting Data Collection. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-27 Rachel E Patzer,Jesse D Schold,Ryutaro Hirose,Jennifer A Cowger,Megan Urbanski,Marie Budev,Ashley Cardenas,Kate Giles,Adrian C Lawrence,Krista L Lentine,Christine Maxmeister,Hellen Oduor,Sumit Mohan,
There is substantial variation in access to transplantation across the United States that is not entirely explained by the availability of donor organs. Barriers to transplantation and variation in care among patients with end-stage organ disease exist prior to patients' placement on a transplant waiting list as well as following waitlist placement. However, there are currently no national data available
-
-
An uncommon complication after living donor nephrectomy Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-25 Vincenzo Villani, Jeffrey H. Fair, Rupak D. Kulkarni
-
The Landscape of Hepatitis C Virus Infection in Pediatric Kidney Transplantation. Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-23 Sarah J Kizilbash,Michael D Evans,Jodi Smith,Rachel M Engen
Hepatitis C virus (HCV) infection is increasing in prevalence due to the growing opioid epidemic; however, its impact on pediatric kidney transplantation is unknown. This study compared kidney transplant outcomes between HCV-positive and propensity-score-weighted HCV-negative pediatric recipients. It also examined HCV-positive kidney utilization for pediatric transplantation in the United States. We
-
Authors' Reply to Letter Regarding "Association of Organ Procurement Organization Volume with CMS Performance Evaluations". Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-22 Rocio Lopez,Sumit Mohan,James R Rodrigue,Susana Arrigain,Deena Brosi,Ryan Lavanchy,Bruce Kaplan,Elizabeth A Pomfret,Jesse D Schold
-
Equitable allocation through human leukocyte antigen eplet matching: a promising strategy with several challenges Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-22 Gonca E. Karahan, Geert W. Haasnoot, Sebastiaan Heidt
-
Association between bariatric surgery after kidney transplantation and graft and survival outcomes Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-22 Elaine Ku, Charles E. McCulloch, Garrett Roll, Deborah Adey, Puneet Sood, Andrew Posselt, Barbara A. Grimes, Kirsten L. Johansen
Bariatric surgery has been shown to be safe in chronic kidney disease and improves access of patients to transplantation. Whether bariatric surgery after kidney transplantation is associated with improved graft or patient survival has not been examined nationally. We included adults with obesity who received a first kidney transplant according to the US Renal Data System between 2003-2019. We matched
-
Downregulation of N6-methyladenosine (m6A) methylation of Sema4D mRNA contributes to Treg dysfunction and allograft rejection Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-21 Yanzhuo Liu, Qiang Fu, Maozhu Yang, Jianli Xu, Zili Zhou, Xingmin Chen, Yanling Zhang, Hao Yuan, Guiqing Jia, Shu He, Lu Yang, Gaoping Zhao
Regulatory T cells (Tregs) have been shown to be involved in the induction of transplantation tolerance in numerous models. Our previous work demonstrated that methyltransferase-like 14 (METTL14) loss impaired Treg function and hindered the establishment of transplantation tolerance. However, the underlying mechanisms remain unclear. In this study, we found that METTL14 knockdown in Tregs significantly
-
A novel Si-based antioxidant agent attenuates antibody-mediated rejection in allogeneic rat kidney transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-21 Masataka Kawamura, Soichi Matsumura, Toyofumi Abe, Yuki Kobayashi, Shota Fukae, Ryo Tanaka, Ayumu Taniguchi, Shigeaki Nakazawa, Kazuaki Yamanaka, Taigo Kato, Tomoko Namba-Hamano, Hikaru Kobayashi, Norio Nonomura, Yoichi Kakuta, Ryoichi Imamura
Antibody-mediated rejection remains a leading cause of graft loss during kidney transplantation. Ischemia reperfusion injury (IRI) has been reported to promote T cell proliferation, leading to B cell activation and subsequent production of donor-specific antibodies, which target antigens on the vascular endothelium. We hypothesize that a novel therapeutic strategy targeting highly toxic reactive oxygen
-
B-cell infiltration distinguishes mucosal from skin patterns of rejection in facial vascularized composite allografts Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-20 Martin Kauke-Navarro, William J. Crisler, Nour Younis, Radhika S. Khetani, Sam Sadigh, Jessica E. Teague, Shannan J. Ho Sui, Christine Ko, Qian Zhan, Samuel Steuart, Nathaniel S. Treister, Jordan Pober, Jamil Azzi, Rachael A. Clark, Bohdan Pomahac
Rejection monitoring in facial vascularized composite allotransplantation traditionally focuses on skin biopsies. However, mucosal rejection frequently presents with more pronounced signs of immune activity. To explore mechanistic differences between skin and mucosal rejection, rejection and nonrejection biopsies from allograft skin and oral mucosa of 9 facial vascularized composite allotransplantation
-
Updating the kidney donor risk index: Removing donor race and hepatitis C virus status Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-19 Jonathan M. Miller, Kelley Poff, Jesse N. Howell, Oscar K. Serrano, Jim Kim, Alejandro Diez, Grace R. Lyden, Bryn W. Thompson, David Zaun, Jon J. Snyder
This study reports the results of a recalculation of the kidney donor risk index (KDRI) formula requested by the Organ Procurement and Transplantation Network’s Minority Affairs Committee to remove the donor race and hepatitis C virus (HCV) status variables. The updated KDRI model was fit on adult, deceased donor, solitary kidney, first-time transplants from 2018-2021. Deceased donors from 2018 through
-
Setting the record straight about normothermic regional perfusion in the setting of donation after circulatory death—facts vs fiction Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-17 Lambros Tsonis, Malcolm MacConmara, Magdy Attia, Farhan Zafar
-
Pancreas irradiation for treatment-resistant acute cellular rejection in a severely immunocompromised pancreas-after-kidney transplant recipient—case report Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-17 Aleksandra Kukla, Scott C. Lester, Anum Iqbal, Raymund R. Razonable, Naim Issa, Samy Riad, Jean C. Fox, Mikel Prieto, Yogish C. Kudva
Treating acute rejection of a pancreas transplant in a severely immunocompromised patient with viral opportunistic infection is challenging due to the balance of rescuing from rejection without worsening the morbidity of infection and prolonging the infection episode. We present a case involving a pancreas-after-kidney transplant in a patient with cytomegalovirus (CMV) high-risk discordance (donor
-
Association between everolimus combination therapy and cancer risk after liver transplantation: A nationwide population-based quasi-cohort study Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-16 Suk-Chan Jang, Gi-Ae Kim, Young-Suk Lim, Hye-Lin Kim, Eui-Kyung Lee
The potential of everolimus (EVR) in reducing hepatocellular carcinoma (HCC) among recipients following liver transplantation has been reported. This nationwide population-based quasi-cohort study investigated whether combining EVR with calcineurin inhibitor therapy affects the risk of HCC and extrahepatic cancers compared to a time duration–matched cohort of recipients not receiving EVR. Using data
-
Continuous donor-recipient age-matching in the Eurotransplant region: outcomes, parameters and prediction Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-16 Maarten Coemans, Maarten Naesens
-
Normothermic regional and ex situ perfusion reduces postreperfusion syndrome in donation after circulatory death liver transplantation: A retrospective comparative study Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-16 Anand Puttappa, Rohit Gaurav, Vibhay Kakhandki, Lisa Swift, Corrina Fear, Rachel Webster, Ahmed Radwan, Musab Mohammed, Andrew Butler, John Klinck, Christopher Watson
In controlled donation after circulatory death (DCD) liver transplantation, ischemia-reperfusion injury is linked to postreperfusion syndrome (PRS), acute kidney injury (AKI), and early allograft dysfunction. Normothermic regional perfusion (NRP) and normothermic machine perfusion (NMP) are techniques that mitigate ischemic injury and associated complications. In this single-center retrospective study
-
Finding actionable information in the universe of data Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-16 Jennifer Gagnon, Lisa M. McElroy
-
Influenza A(H5N1) virus clade 2.3.2.1a in traveler returning to Australia from India, 2024 Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-15 Marcus R. Pereira
-
From hero to zero: a single center retrospective review of the utility of routine physical crossmatching Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-13 Robert A. Bray, Anna B. Morris, Lalit Patel, Robert Bray, Howard M. Gebel, H. Cliff Sullivan
Pretransplantation human leukocyte antigen antibody testing is necessary to assess compatibility between donor and recipient pairs. Over the past decade, the virtual crossmatch (VXM) has replaced the physical crossmatch (PXM) as the main assessment of pretransplant histocompatibility. At our center, most transplants have proceeded based solely on the VXM, followed by a retrospective PXM. In this study
-
A trip down (obesogenic) memory lane Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-11 Sarah Alshammery, Natasha M. Rogers
-
Out-of-sequence allocation: It is useful, but is it ethical? Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-10 Lara C. Pullen PhD
-
-
-
-
-
Can Calcineurin Inhibitor-Free Immunosuppression Become a Reality? Preliminary Results from a Pilot Clinical Study of CD40L Co-Stimulation Blockade for Beta Cell Replacement Therapy Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Nicole Wojcik, Nathan Appelbaum, Braden Juengel, Lindsay Basto, Minelly Escobedo, Alexandra Juszczyk, Irena Kovacevic, Ling-jia Wang, Martin Tibudan, Ivan Nava, Rolf Barth, John Fung, Piotr Witkowski
-
Modified robotic simultaneous pancreas-kidney transplant to decrease the intraperitoneal complication Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Katsunori Miyake, Mario Spaggiari, Luke George Atia, Maria Jimena Alaniz, Pierpaolo Di Cocco, Jorge A. Almario Alvarez, Stephen Bartlett, Ivo Tzvetanov, Enrico Benedetti
-
Impact of NRP on Simultaneous Kidney Pancreas Transplant: A Markov Decision Analysis Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Maria Baimas-George, Marissa Di Napoli, Yanik Bababekov, Shayan Syed Bahktiyar, Armaun Rouhi, Peter Keneally, Trevor Nydam, Rashikh Choudhury
-
Strategic Insights into Organ Donation: Analyzing Perceptions, Attitudes, and Disincentive Removal Effects Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Ana Cecilia Ugalde- Flores, Marco Alejandro Arizmendi-Villarreal, Edelmiro Pérez- Rogríguez, Leslie Monserrat Reyes-Castrejón, Allina P. Flores-Mendoza, Gerardo E. Muñoz-Maldonado, Francisco J. Reyna-Sepúlveda
-
Predictive algorithms for sepsis and septic shock perform poorly among transplant ICU patients Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Katie Ross-Driscoll, Rodica Muraru, Sarah Huber, Nico Barros
-
A Novel African American Transplant Access Program Helps Structurally Disadvantaged Black Patients Access Organ Transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Joy Obayemi, Ateh Fonteh, Mitchell Paukner, Shaina Alexandria, Kiarri Kershaw, Daniela Ladner, Dinee Simpson
-
Integrating Robotics into Transplant Fellowships: Shaping the Next Generation of Transplant Surgeons Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Caleb Harsin, Neeta Vachharajani, Amen Kiani, Angela Hill, Meranda Scherer, Jason Wellen, Maria Doyle, William Chapman, Adeel Khan
-
Perceptions and Potential Barriers to Participation of Nurses in Xenotransplantation Research Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Grant Eickel, Ian Jaffe, Katya Kaplow, Cecilia Deterville, Christopher Hickson, Shushaunna Bennett, Jonah Klapholz, Keilee Luo, Nikki Lawson, Jacqueline Kim, Rebecca Esker, Adam Griesemer, Sapna Mehta, Robert Montgomery, Jeffrey Stern, Philip Sommer, Kathleen Zavotsky, Elaina Weldon, Karen Khalil
-
Cell-free DNA method for monitoring porcine-to-human xenotransplants Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Tudor Constantin, Shou-Chien Kuo, Bernhard Zimmermann
-
Recipient Characteristics Associated with Mortality and Graft Survival of Intestinal Transplantation: A UNOS Database Study Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Laura Cogua, Connor Tupper, Claire Jung, Harshita Raja, William Weber, Meng-Hao Li, Naoru Koizumi, Jorge Ortiz
-
With Mirth and Laughter Let Old Wrinkles Come: A Qualitative Exploration of Transplant Surgeons’ Perceptions of Retirement Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Ritah Chumdermpadetsuk, Adriana Montalvan, Stalin Canizares, Ling Hsiao, Amy Sullivan, Belen Rivera, Devin Eckhoff, David Lee
-
Longitudinal Assessment of Solid Organ Transplant Recipients with SARS-CoV-2 Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Taylor Bradley, Jacqueline Garonzik Wang, David O’Connor, Thomas Friedrich, Nancy Wilson, Jeannina Smith, Rana Mohamed, Alex Shipe, Melanie Benito, Angela Gifford, Maansi Bhasin, Grace VanSleet, Carson DePagter, Alex Richardson, Andrea Weiler, Wanting Wei, Heather Machkovech, Hunter Ries, Pavan Bhimalli, Nicholas Minor, Andrew Lail, Isla Emmen, Will Vuyk, Max Bobholz
-
Intranasal therapy of IGFBP2 ameliorates lung fibrosis Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Angara Sureshbabu, Ross Bremner, Thallachour Mohanakumar
-
A Novel Predictive Index for DCD Lung Transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Jaden Ju, Matthew Stout, Roman Gorchs, Abbas Rana
-
A Pediatric Discard Risk Index to Curtail Allograft Discard Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Abiha Abdullah, Tahir Malik, Jake Lynn, Zeyu Liu, Zohair Jiwani, Parker Kirby, Christian Kelly, Abbas Rana
-
Factors influencing 25-year survival in Pediatric Liver Transplant Recipients Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Garrett Wortham, Megan Crawford, John Miggins, Abbas Rana, John Goss, Nhu Thao Nguyen Galvan
-
Right Lobe Donor Hepatectomy for Living Donor Liver Transplant following Sleeve Gastrectomy: First reported Case from India Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Divyata Vasa, Taher Shaikh, Chetan Kalal, Anil Singh, Anurag Shrimal
-
Using Lactate Clearance at 6 hours and Glucose Metabolism as a Marker for Usability of Liver following Normothermic Machine Perfusion Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Vijay Subramanian, Philopateer Messeha, Olivia Walter, Arni Kumar, Emma Kotelnicki, Milana Mudra, Kaidyn White, Ashish Singhal, Kiran Dhanireddy
-
Controlled Hypothermic Preservation of Donor Livers with Back- to-Base Normothermic Machine Perfusion Improves Clinical Outcomes and Facilitates Donor Pool Expansion Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Vijay Subramanian, Rachel Hogen, Ashish Singhal, Diego Reino, Kiran Dhanireddy
-
Transplantation for unresectable liver-limited colorectal liver metastasis with deceased donor livers: feasibility of an oncological MELD exception points-based protocol Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Eve Simoneau, Zhixia Rong, Frank Vandenbroucke, David Henault, Richard Letourneau, Marylene Plasse, Andre Roy, Michel Dagenais, Simon Turcotte, Peter Metrakos, Prosanto Chaudhury, Genevieve Huard
-
When All Roads Lead to the IMV: An Underutilized Jump Graft Option for Portal Vein Inflow in Complex Liver Transplants Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Sami Shoucair, Kumaran Shanmugarajah, Chase Wehrle, Masato Fujiki, Mazhar Khalil, Andrea Schlegal, Koji Hashimoto, David Kwon, Frederico Aucejo, JaeKeun Kim, Alejandro Pita
-
Effect of Donor-Recipient Age Difference on Liver Transplant Outcomes Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Kasra Shirini, Shani Kamberi, Akram Al Ramlawi, Daniel Maluf, Saad Malik, Josue Alvarez-Casas, Kirti Shetty, Chandra Bhati, Raphael Meier
-
Early hospital readmissions after liver transplant for alcoholic liver disease Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Sarah Shan, Li Ting Tan, Sophia Diaz, Yusuf Ciftci, Vina Nguyen, Andrew Cameron, Elizabeth King
-
Living Donor Liver Transplant for Intrahepatic Cholangiocarcinoma or Mixed Disease: Time for a Paradigm Shift? Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Vrishketan Sethi, Swaytha Ganesh, David Geller, Christopher Hughes, Abhinav Humar, Vikraman Gunabushanam
-
Validation of transplant risk assessment scores within normothermic machine perfusion treated liver transplant cohort Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Sangeeta Satish, Chase Wehrle, Mingyi Zhang, Khaled Ali, Rebecca Panconesi, Muhammad Nadeem, Omer Karakaya, Keyue Sun, Chunbao Jiao, Kumaran Shanmugarajah, Glenn Wakam, Sami Shoucair, Wei Wu, Dylan Isaacson, Jaekeun Kim, David Kwon, Federico Aucejo, Alejandro Pita, Mazhar Khalil, Masato Fujiki, Charles Miller, Koji Hashimoto, Andrea Schlegel
-
UNRAVELING SOCIAL FACTORS EXISTING BETWEEN DONOR-RECIPIENT PAIRINGS IN LIVING DONOR LIVER TRANSPLANTATION Am. J. Transplant. (IF 8.9) Pub Date : 2025-01-08 Brittany Rocque, Justin Weissberg, Matthew Byrne, Karen Pineda-Solis, Koji Tomiyama, Roberto Hernandez Alejandro